A Call to Action: ERS Leadership Engages European Commission to Elevate Respiratory Health on the Political Agenda on August 2, 2026 Posted by
Beyond the Brain: How Obesity-Linked Lipids May Drive Alzheimer’s Progression on August 2, 2026 Posted by
The Vanguard of Discovery: Meet the 2026 Lloyd J. Old STARs and the Future of Immunotherapy on August 2, 2026 Posted by
The Internal Architect of Chaos: Understanding and Overcoming Self-Sabotage in Bipolar Disorder on August 2, 2026 Posted by
The Gold Standard of Core Stability: Why the Two-Minute Plank is the Ultimate Fitness Benchmark After 55 on August 2, 2026 Posted by
A Call to Action: ERS Leadership Engages European Commission to Elevate Respiratory Health on the Political Agenda on August 2, 2026 Posted by
Beyond the Brain: How Obesity-Linked Lipids May Drive Alzheimer’s Progression on August 2, 2026 Posted by
The Vanguard of Discovery: Meet the 2026 Lloyd J. Old STARs and the Future of Immunotherapy on August 2, 2026 Posted by
Posted in Sleep Health Breakthrough in Sleep Medicine: FDA Grants Orphan Drug Designation to Tris Pharma’s Once-Nightly TRN-257 on July 24, 2026
Posted in Sleep Health FDA Grants Orphan Drug Designation to Tris Pharma’s TRN-257, a Potential Breakthrough for Idiopathic Hypersomnia on July 16, 2026
Posted in Mental Health Recovery The "Orphan Phenomenon": The Hidden Crisis of Psychiatric Medication Withdrawal and the Failure of Informed Consent on July 15, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
Posted in Medical Innovations The Resilient Frontier: Why Orphan Drugs Are Thriving Despite a Volatile Pharma Landscape on June 1, 2026 rifanmuazin
